As one of the first facilities to register under section 503B, Pine Pharmaceuticals is celebrating ten years of uncompromising excellence! Founded in 2014 by father and son Alfonse Muto and Alfonse J. Muto, Pharm.D., Pine Pharmaceuticals established itself as an...
Company news
Pine Pharmaceuticals named 2023 BioPharma Business of the Year
We are thrilled to announce that Pine Pharmaceuticals has been honored as Buffalo Business First's 2023 Business of the Year in the BioPharma sector! This remarkable achievement is a testament to the unwavering dedication and tireless efforts of our entire team,...
Pine Pharmaceuticals launches seven new drug products to provide hospitals with life-saving resources nationwide
Tonawanda, NY, October 31, 2023 – Pine Pharmaceuticals, one of the nation's largest and most trusted FDA-registered 503B outsourcing facilities, recently announced the launch of seven new hospital products, strengthening its ability to reduce drug shortages...
MasterControl Award: Excellence in Analytics
We're excited to announce that Pine Pharmaceuticals has been honored with the Excellence in Analytics award by MasterControl. Spearheaded by our Innovation and Development Manager, James Ando, Pharm.D., MasterControl has been pivotal in transforming our reports into...
Pine Pharmaceuticals wins Brick by Brick Award
We're thrilled to announce that Buffalo Business First awarded Pine Pharmaceuticals a Brick by Brick award, recognizing our 50,000-square-foot expansion. These exclusive awards highlight the accomplishments of Western New York's real estate development industry. Thank...
Introducing StaClear® Luer Slip and Norm-Ject® Less Fill
Pine Pharmaceuticals is pleased to introduce StaClear® Luer Slip and NORM-JECT® Less Fill, our all-new syringe options for repackaged bevacizumab. Designed to provide exceptional quality, StaClear® Luer Slip and NORM-JECT® Less Fill syringes now offer a low dead space...
Business First recognizes Pine Pharmaceuticals during 2023 Manufacturing Awards
We are pleased to announce that Buffalo Business First has named Pine Pharmaceuticals a 2023 Manufacturer Award winner. This award recognizes Pine as one of the top family-run businesses in the manufacturing industry and honors owners Al Sr. and Alfonse J. Muto for...
Pine Pharmaceuticals assumes Athenex’s 503B business, preserving over 50 jobs, expanding its product offerings, and serving hospitals and health systems nationwide
Tonawanda, NY, May 3, 2023 /PRNewswire/– Pine Pharmaceuticals, one of the nation's largest and most trusted FDA-registered 503B outsourcing facilities, today announced the successful integration of Athenex's 503B business, including the transfer of people, processes,...
2023 Conferences and Trade Shows
March 17 - 19, 2023 Dallas, TXMay 17 - 20, 2023 Louisville, KY Learn moreMay 22 - 24, 2023 Indianapolis, IN Learn moreJuly 28 - August 1, 2023 Seattle, WA Learn moreAugust 15 - 16, 2023 Las Vegas, NV Learn moreJune 10 - 12, 2022 Orlando, FL Learn more October 23 - 25,...
Pine owners recognized as one of the top Family Businesses of 2022
Buffalo Business First has named Pine Pharmaceuticals a 2022 Family Business Award winner. This recognition will honor owners Al Sr. and Alfonse J. Muto as one of the top multi-generational, family-owned businesses in Western New York. In early 1985, Al Sr. founded...